RAPID ANTIGEN TEST
Authorised for use in Singapore by the Health Science Authority (HSA) under the Pandemic Special Access Route (PSAR)
The INDICAID® COVID-19 Antigen Rapid Test (ART)
Is a lateral flow immunoassay designed for the qualitative detection of SARS-CoV-2 antigens in direct nasal swab samples.
INDICAID was developed by PHASE SCIENTIFIC, a Hong Kong biotech company with support from the Bill & Melinda Gates Foundation, National Institutes of Health (NIH), National Science Foundation (NSF) and UCLA.
Authorised for self-test use in Singapore by the Health Science Authority (HSA) under the Pandemic Special Access Route (PSAR).
Ideal option for the rapid detection of SARS-CoV-2 infection in symptomatic or asymptomatic individuals suspected of infection or in close-contacts with individuals who are COVID-19 positive.
Can be used anywhere, anytime by anyone regardless of vaccination or symptom status.
Clinically validated with high sensitivity and specificity of 96% and 99% respectively.
Proven to be able to detect all COVID-19 variants, including the latest Omicron variant.
INSTRUCTION STEPS FOR USE
ABOUT PHASE SCIENTIFIC
PHASE Scientiﬁc is a high-growth biotech company founded in the United States by Dr Ricky Chiu in 2015. Now headquartered is in Hong Kong, their global footprint includes R&D, manufacturing facilities and offices in Southern California, US and Shenzhen, China.
PHASE Scientific, backed by the Bill and Melinda Gates Foundation, has a patented sample processing technology and aim to bring revolutionary breakthroughs and create changes in health management, focusing on both treatment and prevention.